Literature DB >> 15312851

Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions.

Nicholas Kipshidze1, George Dangas, Mykola Tsapenko, Jeffrey Moses, Martin B Leon, Michael Kutryk, Patrick Serruys.   

Abstract

Restenosis at the site of an endoluminal procedure remains a significant problem in the practice of interventional cardiology. We present current data on intimal hyperplasia, which identify the major role of endothelial cells (ECs) in the development of restenosis. Considering endothelial denudation as one of the most important mechanisms contributing to restenosis, we focus more attention on methods of accelerating restoration of endothelial continuity. Prevention of restenosis may be achieved by promoting endothelial regeneration through the use of growth factors, EC seeding, vessel reconstruction with autologous EC/fibrin matrix, and the use of estrogen-loaded stents and stents designed to capture progenitor ECs.

Entities:  

Mesh:

Year:  2004        PMID: 15312851     DOI: 10.1016/j.jacc.2004.04.048

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  99 in total

Review 1.  Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.

Authors:  Yasushi Matsuzawa; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-12       Impact factor: 1.439

2.  In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula.

Authors:  Jie Cui; Chase W Kessinger; Jason R McCarthy; David E Sosnovik; Peter Libby; Ravi I Thadhani; Farouc A Jaffer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-13       Impact factor: 8.311

Review 3.  Restenosis after PCI. Part 2: prevention and therapy.

Authors:  J Wouter Jukema; Tarek A N Ahmed; Jeffrey J W Verschuren; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-10-11       Impact factor: 32.419

Review 4.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

5.  Prevention of restenosis: is angioplasty the answer?

Authors:  Bruno Scheller; Ulrich Speck; Michael Böhm
Journal:  Heart       Date:  2007-05       Impact factor: 5.994

Review 6.  The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

Authors:  Thierry Charron; Nafiseh Nili; Bradley H Strauss
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

7.  Disappearance of a small intracranial aneurysm as a result of vessel straightening and in-stent stenosis following use of an Enterprise vascular reconstruction device.

Authors:  Koichiro Takemoto; Satoshi Tateshima; Sachin Rastogi; Nestor Gonzalez; Reza Jahan; Gary Duckwiler; Fernando Vinuela
Journal:  BMJ Case Rep       Date:  2013-01-17

8.  Scaffold-free in vitro arterial mimetics: the importance of smooth muscle-endothelium contact.

Authors:  Somali Chaterji; Kinam Park; Alyssa Panitch
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

9.  Promoting Endothelial Cell Affinity and Antithrombogenicity of Polytetrafluoroethylene (PTFE) by Mussel-Inspired Modification and RGD/Heparin Grafting.

Authors:  Hao-Yang Mi; Xin Jing; James A Thomsom; Lih-Sheng Turng
Journal:  J Mater Chem B       Date:  2018-05-09       Impact factor: 6.331

Review 10.  Advances in nanotechnology for the management of coronary artery disease.

Authors:  June-Wha Rhee; Joseph C Wu
Journal:  Trends Cardiovasc Med       Date:  2012-12-13       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.